AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma Meeting Abstract
| Authors: | Wainberg, Z. A.; Chung, V.; Devoe, C. E.; George, T. J.; Welkowsky, E.; Kheoh, T.; Haqq, C. M.; Pant, S.; O'Reilly, E. M. |
| Abstract Title: | AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Keywords: | 261-492-341; 38092-25821; 261-7540; 298-145-222-184-1022-9124; 3282-206-4957-326-5009-5024-5025; 3282-646-4685-2424; 130-2818-337; 613-545-552 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500196 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.TPS720 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS720 -- Source: Wos |
